Literature DB >> 10431771

Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures.

T Büttner1, B Lack, M Jäger, W Wünsche, W Kuhn, T Müller, H Przuntek, T Postert.   

Abstract

Serum neuron-specific enolase (s-NSE) and s-100 protein (s-100) are sensitive markers of various brain diseases. We investigated both of these markers in nine patients within 5 min, 6 h, 12 h, and 48 h after a single tonic-clonic seizure. The mean peak s-NSE level was significantly higher after 5 min (11.97 +/- 8.56 microg/l) and 48 h (10.31 +/- 8.92 microg/l, P < 0.05) than the levels of seizure-free, age-matched controls. Five patients had increased s-NSE levels regarding the upper limit of normal as mean + 3 SD. s-100 was not detected either in controls or epileptic patients. These data indicate that s-NSE in contrast to s-100 may be an in vivo marker after generalized seizures in some patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431771     DOI: 10.1007/s004150050383

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  8 in total

1.  Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope.

Authors:  Seung-Yeob Lee; Young-Chul Choi; Jeong-Ho Kim; Won-Joo Kim
Journal:  J Neurol       Date:  2010-06-08       Impact factor: 4.849

2.  Do single seizures cause neuronal death in the human hippocampus?

Authors:  Luisa L Rocha; Maria-Leonor Lopez-Meraz; Jerome Niquet; Claude G Wasterlain
Journal:  Epilepsy Curr       Date:  2007 May-Jun       Impact factor: 7.500

3.  In vitro status epilepticus but not spontaneous recurrent seizures cause cell death in cultured hippocampal neurons.

Authors:  Laxmikant S Deshpande; Jeffrey K Lou; Ali Mian; Robert E Blair; Sompong Sombati; Robert J DeLorenzo
Journal:  Epilepsy Res       Date:  2007-07       Impact factor: 3.045

4.  Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure.

Authors:  Stefania Mondello; Johanna Palmio; Jackson Streeter; Ronald L Hayes; Jukka Peltola; Andreas Jeromin
Journal:  BMC Neurol       Date:  2012-08-29       Impact factor: 2.474

5.  Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Chen-Chang Lee; Shang-Der Chen; Wen-Neng Chang; Cheng-Hsien Lu; Nai-Ching Chen; Alice Y W Chang; Samuel H H Chan; Yao-Chung Chuang
Journal:  BMC Neurol       Date:  2012-03-14       Impact factor: 2.474

6.  Brain metastases at the time of presentation of non-small cell lung cancer: a multi-centric AERIO analysis of prognostic factors.

Authors:  W Jacot; X Quantin; J M Boher; F Andre; L Moreau; M Gainet; A Depierre; E Quoix; T L Chevalier; J L Pujol
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

Review 7.  Clinical neuropathology practice guide 5-2013: markers of neuronal maturation.

Authors:  Harvey B Sarnat
Journal:  Clin Neuropathol       Date:  2013 Sep-Oct       Impact factor: 1.368

8.  Comparison of the target-controlled infusion and the manual infusion of propofol anesthesia during electroconvulsive therapy: an open-label randomized controlled trial.

Authors:  Meng-Ling Hsieh; Yen-Ting Lu; Chih-Chung Lin; Chin-Pang Lee
Journal:  BMC Psychiatry       Date:  2021-02-04       Impact factor: 3.630

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.